Top Stock Movers Now: Wynn Resorts, AT&T, Newmont, and More
U.S. equities were mixed at midday as the Federal Reserve's favored measure of inflation was lower than anticipated.
First novel Schizophrenia treatment in decades gains FDA approval
The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...
New schizophrenia drug ‘could change the lives of millions of people’
The US Food and Drug Administration has approved Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.
Stock Market Today: Wall Street Drifts Around Its Records as Chinese Stocks Close a Monster Week
U.S. stock indexes are drifting around their records as hopes hold that the economy can pull off the feat of getting ...
btimesonline53m
FDA Approves Bristol Myers Squibb’s Cobenfy, First Novel Schizophrenia Drug in 70 Years
Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking ...
These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava, Wynn, HP Inc., Acadia Healthcare, and More
Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...
FDA Approves the First New Schizophrenia Drug in Decades
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...